| Model Number |
PLL161407 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Code |
Aneurysm (1708)
|
| Date of Event |
02/21/2020
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
The following information was reported to gore through the pivotal study for the gore® excluder® thoracoabdominal branch endoprosthesis (tambe device): on (b)(6) 2020, the patient was implanted with a gore® contralateral leg endoprostheses, and a gore® viabahn® vbx balloon expandable endoprostheses with the gore® excluder® thoracoabdominal branch endoprosthesis (tambe device).The patient was being treated for an aortic aneurysm involving the visceral vessel(s).It was reported that on (b)(6) 2020, images revealed a type ic endoleak.The type ic endoleak identified on 1 month duplex us and cta scan.Patient scheduled for reintervention surgery with dr.(b)(6) to treat the type ic endoleak.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional devices implanted and/or related to this event: plc201400/ 21428790 udi (b)(4).Patient medications: heparin, clopidogrel and aspirin.
|
| |
|
Additional Manufacturer Narrative
|
|
Correction additional information determined which device had the adverse event reported (type ic endoleak) on it.The (gore® viabahn® vbx balloon expandable endoprosthesis) has the allegation of deficiency.The medwatch (report # 2017233-2022-03048).The gore® excluder® aaa endoprosthesis pll161407 lot # 21362777 and the plc201400 lot # 21428790 has no product problem or deficiency caused or contributed to an adverse event/incident for the patient.The medwatch (report # 3013164176-2022-01415) will be retracted.
|
| |
|
Search Alerts/Recalls
|